Xenon Pharmaceuticals (XENE) PT Raised to $77 at BofA Securities

March 12, 2026 4:40 PM

BofA Securities analyst Jason Gerberry raised the price target on Xenon Pharmaceuticals (NASDAQ: XENE) to $77.00 (from $50.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found